Hyperfine, Inc. Class A

Stage 4 · Declining · week 11

As of Oct 22, 2026, Hyperfine is in Stage 4, the downtrend phase, now in week 11 (since Aug 12, 2026). It closed at $0.73, 61.2% below its 52-week high and below its 200-day average, which is falling.

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. More about the company

$0.73

-0.21% today

$77.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is HYPR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 19w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 4w → S3 8w → S4 19w → S1 4w → S4 12w → S1 6w → S2 6w → S3 5w → S4 12w → S1 1w → S2 7w → S3 2w → S4 12w → S1 6w → S2 13w → S3 12w → S2 8w → S1 4w → S2 11w → S3 4w → S4 10w current

Total tracked: 165 weeks across 21 stage runs.

HYPR among Medical Devices85th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…85	HYPRHyperfine, Inc. Class A	Stage 4 · wk 11	26	−8.1%

vs 52W High

-61.2%

$0.73 lo$1.87 hi

61.2% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 11

1w13w26w

Week 11, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-36.3%

200 DMA: $1.14 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.64x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↗

Short-term trend rising gently

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-8.1%

-23.9%

-43.3%

YTD

-25.1%

-43.3%

Scan Membership

Breakout Watch

Latest: 2025-02-04

5 appearances in last 60 days. First seen: 2021-12-02.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 11 · Vol 0.64x

2026-10-21S4

Wk 10 · Vol 0.61x

2026-10-20S4

Wk 10 · Vol 0.34x

2026-10-19S4

Wk 10 · Vol 0.42x

2026-10-16S4

Wk 10 · Vol 0.70x

2026-10-15S4

Wk 10 · Vol 1.19x

2026-10-14S4

Wk 9 · Vol 0.98x

2026-10-13S4

Wk 9 · Vol 0.68x

2026-10-12S4

Wk 9 · Vol 1.28x

2026-10-09S4

Wk 9 · Vol 2.65x

2026-10-08S4

Wk 9 · Vol 20.42x

2026-10-07S4

Wk 8 · Vol 0.88x

Moving averages & range

50 DMA

$0.83

200 DMA

$1.14

52W High

$1.87

52W Low

$0.73

5D Low

$0.73

Resistance levels (recent highs)

20d High

$0.94

60d High

$1.02

120d High

$1.81

250d High

$1.87

Next resistance

+29.5%

to 20d High

ROE

-97.0%

Profit margin -210.8%

Dividend Yield

0.00%

P/B 2.1

Hyperfine: quick answers

What stage is Hyperfine in?

As of Oct 22, 2026, Hyperfine (HYPR) is in Stage 4, the downtrend phase. It entered Stage 4 on Aug 12, 2026 and is in week 11. What the four stages mean

Is Hyperfine in an uptrend?

No. Hyperfine is in a Stage 4 downtrend. It trades 36.3% below its 200-day average, which is falling.

How far is Hyperfine from its 52-week high?

Hyperfine closed at $0.73 on Oct 22, 2026, 61.2% below its 52-week high of $1.87. Its 52-week low is $0.73.

How has Hyperfine performed over the past year?

As of Oct 22, 2026, Hyperfine is down 43.3% over the past year and down 25.1% so far in 2026.

Which sector and industry is Hyperfine in?

Hyperfine is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredited facilities through direct sales and distributors in the United States, Canada, the United Kingdom, other European and Middle Eastern markets, Australia, and New Zealand. The company was founded in 2014 and is based in Guilford, Connecticut.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.